Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Hepato-Biliary

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Non‐serious adverse events · patients with covert or overt hepatic encephalopathy

It is very uncertain whether acetyl‐L‐carnitine changes non‐serious adverse events compared with placebo (very low certainty).

1 finding from 1 review

Acetyl‐L‐carnitine for patients with hepatic encephalopathy 2019 · Cochrane Headline outcomes only
RR 2.51 [0.68, 9.22]
2 studies · 246 participants
Very low